Literature DB >> 10224524

Reactive nitrogen and oxygen intermediates in patients with cutaneous leishmaniasis.

O Erel1, A Kocyigit, V Bulut, M S Gurel.   

Abstract

The metabolisms of reactive nitrogen and oxygen intermediates (RNI and ROI) in patients with cutaneous leishmaniasis (CL) were investigated and compared with those of healthy subjects. To determine RNI metabolism, nitrite plus nitrate concentrations were measured spectrophotometrically. Nitrite concentration in plasma was determined directly by the Griess method. Nitrate levels in plasma were measured after reduction into nitrite by using copper-cadmium-zinc. ROI metabolism was evaluated by measuring erythrocyte superoxide dismutase, catalase and glutathione peroxidase activities. Plasma nitrite plus nitrate levels and erythrocyte superoxide dismutase activity were higher in the patient group than healthy subjects (p<0.01). In contrast, erythrocyte catalase and glutathione peroxidase activities were lower (p<0.05, p<0.01, respectively). ROI metabolism was altered in relation to hydrogen peroxide elevation in patients with CL. These alterations in ROI enable nitric oxide (NO) to amplify its leishmanicidal effect. The determination of ROI and RNI in patients with CL may be a useful tool to evaluate effector mechanisms of NO and clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10224524     DOI: 10.1590/s0074-02761999000200009

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  9 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Superoxide dismutase and Glutathione peroxidase in the blood of dogs with Leishmaniasis.

Authors:  D Britti; S Sconza; V M Morittu; D Santori; A Boari
Journal:  Vet Res Commun       Date:  2008-09       Impact factor: 2.459

3.  Antimonial therapy induces circulating proinflammatory cytokines in patients with cutaneous leishmaniasis.

Authors:  Abdurrahim Kocyigit; Selahaddin Gur; Mehmet S Gurel; Vedat Bulut; Mustafa Ulukanligil
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  Expression of inducible nitric oxide synthase in human cutaneous leishmaniasis.

Authors:  Gamze Serarslan; Esin Atik
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

5.  Erythrocyte glutathione status in human visceral leishmaniasis.

Authors:  D P Neupane; S Majhi; L Chandra; S Rijal; Nirmal Baral
Journal:  Indian J Clin Biochem       Date:  2008-03-06

6.  Anti-leishmanial effects of trinitroglycerin in BALB/C mice infected with Leishmania major via nitric oxide pathway.

Authors:  Hossein Nahrevanian; Mana Najafzadeh; Reza Hajihosseini; Habib Nazem; Mahin Farahmand; Zahra Zamani
Journal:  Korean J Parasitol       Date:  2009-05-27       Impact factor: 1.341

7.  Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial function.

Authors:  Nadya Merchant; Charles D Searles; Anbu Pandian; Syed T Rahman; Keith C Ferdinand; Guillermo E Umpierrez; Bobby V Khan
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-12       Impact factor: 3.738

8.  Inhibition of Murine Systemic Leishmaniasis by Acetyl Salicylic Acid via Nitric Oxide Immunomodulation.

Authors:  H Nahrevanian; M Jalalian; M Farahmand; M Assmar; Ar Esmaeili Rastaghi; M Sayyah
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

9.  Parasitological and biochemical studies on cutaneous leishmaniasis in Shara'b District, Taiz, Yemen.

Authors:  Qhtan Asmaa; Salwa Al-Shamerii; Mohammed Al-Tag; Adam Al-Shamerii; Yiping Li; Bashir H Osman
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-07-04       Impact factor: 3.944

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.